<?xml-stylesheet type="text/xsl" href="./datadict_v2.xsl"?><data_table id="pht003417.v3" study_id="phs000200.v11" participant_set="3" date_created="Wed Jun 14 08:35:43 2017"><description>Specimen Study Case-Control Types</description><unique_key phv="00193840" version="3">SUBJID</unique_key><unique_key phv="00193841" version="3">STUDYID</unique_key><unique_key phv="00193842" version="3">CCNAME</unique_key><variable id="phv00193840.v3"><name>SUBJID</name><description>WHI dbGaP Subject ID</description><type>integer</type></variable><variable id="phv00193841.v3"><name>STUDYID</name><description>Study ID</description><type>encoded value</type><value code="83">Thrombotic, inflammatory and genetic markers for CHD</value><value code="105">Carotenoids in age-related eye disease study (CAREDS)</value><value code="110">Sex hormones and CHD</value><value code="126">Stroke risk factors and molecular markers</value><value code="132">Genetic and biochemical predictors of type 2 diabetes</value><value code="181">Hip fracture estradiol, cytokines, bone turnover</value><value code="346">Serum, vitamin D, and risk of melanoma in WHI-OS</value><value code="383">VitD/BR and Colorectal Ca</value><value code="422">Cardiovascular biomarkers in WHI Native Americans</value><value code="BA10">Adipokines and risk of obesity-related disease</value><value code="BA25">Leukocyte Telomere Dynamics</value><value code="BA9">Biochemical antecedents of fracture in minority women</value><value code="W1">CT 6% Subsample, Clinic CBCs, QC Pools</value><value code="W2">OS-measurement precision study (OS-MPS)</value><value code="W5">Endogenous sex hormones in DM trial</value><value code="W6">HT CVD Biomarkers: study of CHD, Stroke and VTE - Phase I</value><value code="W9">Sex hormones and fractures</value><value code="W10">Biological markers of the effect of HT on breast cancer</value><value code="W11">CVD biomarkers - Phase II:  strokes after Feb. 2001</value><value code="W14">CVD biomarkers - Phase I: additional asays</value><value code="W15">Vit D and colorectal cancer or fractures in CaD trial</value><value code="W18">HT Hormone Pretest</value><value code="W22">Vitamin D levels in 6% blood subsample of CaD</value><value code="W24">Vitamin D and breast cancer in CaD trial</value><value code="W39">27-hydroxycholesterol in CVD biomarkers (W-6)</value><value code="W45">Proteomic Colon Cancer Study</value><value code="W54">CVD Biomarkers for 2010-2015 (SHARe cohort only)</value><value code="W57">HT Proteomics on B2M and IGFBP4</value><value code="W58">CVD, diabetes, and renal biomarkers in the EA HT Cohort</value><value code="W64">Long Life Study (LLS)</value><value code="W66">Long Life Study-Phase III Biomarkers and GWAS</value></variable><variable id="phv00193842.v3"><name>CCNAME</name><description>Case Control Type Name</description><type>string</type><comment>A short name describing the case control type.</comment></variable><variable id="phv00193843.v3"><name>CASEFLG</name><description>Case Flag</description><type>encoded value</type><comment>Y=Case, N=Control, N/A=Study was not a case/control design.
		Note that in some studies the same participant may act as both a case and a control (e.g. studies looking at multiple outcomes). </comment><value code="N">No - Control</value><value code="NA">Not Applicable</value><value code="Y">Yes - Case</value></variable></data_table>
